These data, together with our recent findings that p-eIF4E is highly upregulated in AML-M5 patients (Supplementary Fig. S1A–B), attempted us to reason that HHT may inhibit growth of AML cells via directly targeting p-eIF4E. This evidence concerns the gene EIF4E and acute myeloid leukemia.